Diagnosis

Pleural effusion

Abnormal collection of fluid in the pleural space (between parietal and visceral pleura) resulting from excess fluid production or decreased absorption.

Etiology

Cause [twi]

Pathophysiology [twi]

  1. Normal pleural fluid serves as a lubricant to facilitate movement of the pleural surfaces against each other in the course of respirations

  2. This small volume of fluid is maintained through the balance of hydrostatic and oncotic pressure and lymphatic drainage

  3. Exudate:

    • Altered pleural permeability: pneumonia, malignancy, pulmonary embolism

    • Increased capillary permeability: trauma, malignancy, inflammation, pulmonary embolism, drug hypersensitivity, renal failure, pancreatitis

  4. Transudate:

    • Decreased intravascular oncotic pressure: decreased albumin, cirrhosis

    • Increased capillary hydrostatic pressure: heart failure, vena cava syndrome

    • Decreased pressure in the pleural space (preventing full lung expansion): atelectasis, mesothelioma

    • Decreased lymphatic drainage: malignancy, trauma

    • Transudation from ascites or pulmonary edema

  5. The net result may be compression of the lungs --> restrictive ventilatory defect:

    • Dyspnea

    • Chest pain

    • Cough

Complications [twi]

Epidemiology

Incidence per 100.000 [ksd][pzp][yms][nuy][4kb][i4p][sab]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Cough, Decreased respiratory sounds, Dyspnea, Edema, Fever, Hemoptysis, Orthopnea, Tracheal deviation

Clinical findings

Decreased Albumin, Hypoxemia

Anamneses

None listed.

Localized findings

Pain
Radiates
Thorax
Onset
Gradual (days)
Pattern
Constant
Provoked by
Respiration
Quality
SharpStabbing
Severity
Mild (1-3)Moderate (4-7)Severe (8-10)

Approach

Light’s criteria to distinguish transudates and exudates [twi]

Exudative meets ≥1 of the following criteria; a transudate meets none of the criteria:

Heffner's criteria for exudative effusion [twi]

Pleural effusion analysis

Treatment

  1. Treating the underlying cause [hdn]

  2. Goals:

    • Sterilization of pleural fluid

    • Reexpansion of the lung

    • Restoration of normal lung function

  3. Antibiotics

  4. Thoracocentesis: compromising respiratory function

    • Pleural drainage

    • Chest tube drainage with or without instillation of fibrinolytic agents

  5. Surgery:

    • Video-assisted thoracoscopic surgery

    • Open thoracotomy with decortication

Differential diagnoses

Abdominal abscess, Acute pancreatitis, Acute renal failure, Acute respiratory distress syndrome, Amyloidosis, Atelectasis, Breast cancer, Chronic renal failure, Chylothorax, Crohn disease, Esophageal perforation, Esophageal rupture, Heart failure, Hemothorax, Hypothyroidism, Leukemia, Lung cancer, Lymphoma, Meigs syndrome, Mesothelioma, Nephrotic syndrome, Pericarditis, Peritonitis, Pneumonia, Pulmonary edema, Pulmonary embolism, Renal failure, Rheumatoid arthritis, Sepsis, Superior vena cava syndrome, Systemic lupus erythematosus, Tuberculosis, Ulcerative colitis, Yellow nail syndrome


References

[1] Krishna R, Antoine MH, Alahmadi MH, et al. Pleural Effusion. [Updated 2024 Aug 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448189/

[2] Botana Rial M, Pérez Pallarés J, Cases Viedma E, López González FJ, Porcel JM, Rodríguez M, Romero Romero B, Valdés Cuadrado L, Villena Garrido V, Cordovilla Pérez R. Diagnosis and Treatment of Pleural Effusion. Recommendations of the Spanish Society of Pulmonology and Thoracic Surgery. Update 2022. Arch Bronconeumol. 2023 Jan;59(1):27-35. English, Spanish.

[3] Mummadi SR, Stoller JK, Lopez R, Kailasam K, Gillespie CT, Hahn PY. Epidemiology of Adult Pleural Disease in the United States. Chest. 2021 Oct;160(4):1534-1551.

[4] Sorg AL, Obermeier V, Liese JG, von Kries R. Incidence trends of parapneumonic pleural effusions/empyema in children 2009 to 2018 from health insurance data: Only temporal reduction after the introduction of PCV13. Vaccine. 2021 Jun 11;39(26):3516-3519.

[5] Wiese AD, Griffin MR, Zhu Y, Mitchel EF Jr, Grijalva CG. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine. 2016 Dec 7;34(50):6243-6249.

[6] Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, Kaplan S, Carroll KC, Daly JA, Christenson JC, Samore MH. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002 Feb 15;34(4):434-40.

[7] Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006 Mar;25(3):250-4.

[8] Deceuninck G, Quach C, Panagopoulos M, Thibeault R, Côté-Boileau T, Tapiéro B, Coïc L, De Wals P, Ovetchkine P. Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007. J Pediatric Infect Dis Soc. 2014 Jun;3(2):119-26.

[9] Shin EJ, Kim Y, Jeong JY, Jung YM, Lee MH, Chung EH. The changes of prevalence and etiology of pediatric pneumonia from National Emergency Department Information System in Korea, between 2007 and 2014. Korean J Pediatr. 2018 Sep;61(9):291-300.

[10] https://emedicine.medscape.com/article/1003121

[11] http://emedicine.medscape.com/article/299959 (2014-01-06); [Medscape]

[12] Mahon C, Walker W, Drage A, Best E. Incidence, aetiology and outcome of pleural empyema and parapneumonic effusion from 1998 to 2012 in a population of New Zealand children. J Paediatr Child Health. 2016 Jun;52(6):662-8.

Scroll to top